Picture loading failed.

Anti-AOC3 therapeutic antibody (Pre-made Timolumab biosimilar,Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

TECHNOLOGY. DESCRIPTION. Timolumab (BTT-1023; SI-3106; SI-636) is a fully human, monoclonal, anti-vascular adhesion protein- 1 (VAP-1) antibody which works by blocking the adhesion function of VAP-1 which diminishes. leucocyte entry to sites of inflammation.

Order informatioin

Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-577-1mg 1mg 3090
GMP-Bios-ab-577-10mg 10mg 21890
GMP-Bios-ab-577-100mg 100mg 148000
GMP-Bios-ab-577-xmg >100mg Inquiry
Shipping Cost: 760.00


Products Name (INN Index) Anti-AOC3 therapeutic antibody (Pre-made Timolumab biosimilar,Whole mAb)
INN Name Timolumab
FormatWhole mAb
Species ReactivityHuman
CH1 IsotypeIgG4
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-II
Est. StatusDiscontinued
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2015
Year Recommended2016
CompaniesAcorda Therapeutics;Biotie Therapies Corp.;Seikagaku Corporation
Conditions Approvedna
Conditions Activena
Conditions DiscontinuedInflammation;Plaque psoriasis;Rheumatoid arthritis;Primary sclerosing cholangitis
Development Techna